---
document_datetime: 2023-09-21 19:20:12
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/stivarga-epar-all-authorised-presentations_en.pdf
document_name: stivarga-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7173235
conversion_datetime: 2025-12-31 04:53:22.370327
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form   | Route of administration   | Immediate Packaging   | Pack size      |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|----------------|
| EU/1/13/858/001  | Stivarga          | 40 mg      | Film-coated tablet    | Oral use                  | bottle (HDPE)         | 28 tablets     |
| EU/1/13/858/002  | Stivarga          | 40 mg      | Film-coated tablet    | Oral use                  | bottle (HDPE)         | 3 x 28 tablets |